Tuberculosis (TB) is a major global health problem especially in the developing world [
1]. In 2020, TB was the thirteenth leading cause of death. Approximately 1.5 million including 214,000 people with HIV died of TB in 2020 [
1]. According to the World Health Organization estimates, the incidence of TB is 10 million cases per year and 98% of them are from the developing world. Extrapulmonary TB accounts for 15–20% of reported cases [
2,
3]. Among extrapulmonary TB, Genitourinary tuberculosis (GUTB) is the second commonest (20 to 40%) in most developed countries and the third commonest in most developing countries [
2]. Moreover, GUTB is seen to coexist in 2–20% of patients with pulmonary TB [
3]. Miliary TB with disseminated haematogenous spread to the genitourinary system is believed to be the cause for GUTB in 25–60% of patients [
2]. Haematogenous seeding of primary TB infection to the kidney leads to granuloma formation which may subsequently caseate and rupture into the tubular lumen spreading to the distal urinary tract. The chronic and insidious nature of TB results in gradual damage to the genitourinary tract by a combination of chronic inflammation, necrosis, abscess formation and scarring leading to direct injury or indirect injury secondary to obstruction [
2,
3].
Sri Lanka is a South Asian tropical country with a population of 22 million. Although GUTB is the second commonest source of extrapulmonary TB in most countries, the reported rate of GUTB in Sri Lanka remains very low [
4]. According to the National Programme for TB control and chest diseases (NPTCCD), only 4 GUTB cases were reported out of 1966 cases of extrapulmonary TB in 2007. Furthermore in 2019, only 59 GUTB cases were reported out of 2431 cases of extrapulmonary TB (8900 TB cases in total) [
5]. This may be due to failure in case detection or deficiencies in proper reporting and documentation. In Sri Lanka, the characteristics of GUTB are not known due to paucity of data [
4]. Only few case reports have been published describing rare manifestations of GUTB [
6‐
9]. Knowing the disease characteristics is vital to establish early diagnosis, treatment and prevention of chronic kidney disease. Therefore, we aimed to study the clinical and imaging characteristics, diagnostic features, treatment modalities and outcome of GUTB in Sri Lanka.
Methods
An observational study was conducted at two tertiary care Urology Units in Sri Lanka, first in Karapitiya Teaching Hospital, Galle from 1.1.2000 to 30.11.2009 and subsequently at Colombo South Teaching Hospital, Dehiwala from 1.12.2009 to 30.6.2021 (a total period of 21 years) where the senior author worked. All patients with a diagnosis of GUTB, i.e. TB involving the kidney, ureters, bladder, urethra, prostate, testis and epididymis were included in the analysis. All study participants were referred to the Urology Clinic as routine referrals or admitted directly to the emergency department with acute clinical presentations. None of the patients were referred with a diagnosis of GUTB. The data were collected prospectively from the patients at the point of diagnosis and the records were updated during their routine follow up clinic visits. Since the data collected were information that was gathered during routine clinical care, there was no special interview done specifically for the study. Thus, this was a retrospective analysis of prospectively collected data. Approval for the study was obtained from the Ethics Review Committee of the Colombo South Teaching Hospital. The study was performed in accordance with the Declaration of Helsinki and all methods were performed in accordance with the relevant guidelines and regulations.
Clinical characteristics including comorbidities, contact or past history of TB and clinical symptoms and signs were recorded. All patients underwent basic biochemical assessment including erythrocyte sedimentation rate (ESR) and serum creatinine. Mantoux test was done in all patients except when the purified protein derivative was not available for the skin test. An induration of ≥ 10 mm was recorded as a positive test in non-immunocompromised patients [
3]. Ultrasound scan of the kidney, ureter, bladder and prostate (US-KUBP) and X-ray KUB were performed in all patients. Patients with symptoms related to the scrotum underwent an additional scrotal ultrasonography. Computed tomography urogram (CTU) was performed in all patients except in those with isolated scrotal symptoms and signs and negative US-KUBP and X-ray KUB. Abnormal findings noted in imaging were denoted according to the anatomical region and involved organ.
Investigations such as urine for acid fast bacilli (AFB), urine for TB culture and polymerase chain reaction (PCR) were performed in order to obtain a microbiological diagnosis. However, in a subset of patients, some of these investigations were not performed due to non-availability of reagents and resources. Selected patients underwent a cystoscopy and bladder biopsy. Indications for cystoscopy included history of haematuria, lower urinary tract symptoms or ultrasonographic or CTU evidence of bladder abnormalities such as increased bladder wall thickness, contracted bladder and mass lesions in the bladder. Bladder biopsy was performed in those with evidence of contracted bladder, mass lesion or inflammatory changes of the urothelium. A histological diagnosis GUTB was made when aggregates of epithelioid histiocytes, Langhans giant cells and caseating necrosis were present [
10].
All patients were screened for pulmonary TB with a clinical assessment and mandatory chest X-ray and sputum AFB. TB of other regions were screened with a clinical history and examination of the lymph nodes and spine. Those with positive findings were subjected to further evaluation.
A diagnosis of GUTB was made in the presence of at least one of the following criteria in addition to clinical features: (1) at least one out of three urine samples were positive for AFB using Ehrlich–Ziehl–Neelsen (EZN) technique. Three consecutive, early morning, mid-stream samples of urine were obtained for the test (2) positive urine or tissue culture for
Mycobacterium tuberculosis complex (3) positive PCR for
Mycobacterium tuberculosis complex (4) histological evidence of TB such as chronic granulomatous inflammation with Langhans giant cells with or without caseation [
3]. The reporting of histopathology and radiological imaging were done partly by authors of the study. However every patient was discussed at a multidisciplinary team (MDT) meeting where many specialists on the subject who were not authors of the study were involved in final reporting and decision making.
Patients were commenced on anti-TB therapy (ATT) as direct observed therapy (DOT) which is mandatory in Sri Lanka to enhance compliance and minimise default rate and lost to follow up. The adverse effects of ATT such as skin reactions and hepatotoxicity were also recorded. Hepatotoxicity due to ATT was defined as (1) at least a fivefold elevation in alanine transaminase (ALT) and/or aspartate transaminase above the upper limit of normal (2) more than 1.5 mg/dL increase in the total bilirubin level (3) clinical features of acute liver derangement such as loss of appetite, jaundice, vomiting, nausea, encephalopathy and at least a threefold rise in ALT and/or AST levels [
3].
Selected patients not responding to ATT or who developed complications such as stricture or abscess formation underwent invasive procedures. These included minimally invasive procedures such as percutaneous drainage, cystoscopy and stenting and open procedures such as open drainage and reconstructive surgical procedures. Complications such as thimble bladder syndrome and progressive deterioration of renal function were also recorded. Estimated GFR (eGFR) was used to measure renal function. Compared to the eGFR at diagnosis, an increase of eGFR ≥ 10% at completion of treatment was defined as “recovery”. An increase or decrease of 0–9% was defined as “stability” and a lowering of ≥ 10% was considered as “deterioration” [
3]. End stage renal disease (ESRD) was defined as eGFR less than 15 mL/min/1.73 m
2 or requiring renal replacement therapy or transplant [
11]. Thimble bladder syndrome was defined as disabling storage symptoms with bladder capacity of < 150 mL as measured by filling the bladder with saline during cystoscopy.
All patients were seen 6 months after completion of ATT with US-KUBP and serum creatinine. Thereafter, those with structural abnormalities of the urinary tract in US-KUBP, high serum creatinine, single functioning kidney and those who had reconstructive surgery were followed up with annual US-KUBP and serum creatinine.
Statistical analyses were performed using SPSS software version 17. Data were expressed as frequency and percentages or median and range as relevant. Non-parametric tests were used to determine associations and statistical significance. Associations between categorical variables were determined using Chi-square test and associations between continuous and categorical variables were determined using Mann–Whitney U test. A p value of less than 0.05 was considered statistically significant.